175 related articles for article (PubMed ID: 10837787)
1. Purification and chemical modifications of hemoglobin in developing hemoglobin based oxygen carriers.
Haney CR; Buehler PW; Gulati A
Adv Drug Deliv Rev; 2000 Feb; 40(3):153-69. PubMed ID: 10837787
[TBL] [Abstract][Full Text] [Related]
2. Site-specific modifications and toxicity of blood substitutes. The case of diaspirin cross-linked hemoglobin.
D'Agnillo F; Alayash AI
Adv Drug Deliv Rev; 2000 Feb; 40(3):199-212. PubMed ID: 10837790
[TBL] [Abstract][Full Text] [Related]
3. Red cell substitutes.
Winslow RM
Semin Hematol; 2007 Jan; 44(1):51-9. PubMed ID: 17198847
[TBL] [Abstract][Full Text] [Related]
4. [Modified hemoglobins as oxygen transporting blood substitutes ].
Waschke KF
Anaesthesist; 1995 Jan; 44(1):1-12. PubMed ID: 7695075
[TBL] [Abstract][Full Text] [Related]
5. A convenient method for the determination of the solubility of hemoglobin and modified hemoglobins.
Anderson PJ; Biro GP
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):753-61. PubMed ID: 7994398
[TBL] [Abstract][Full Text] [Related]
6. All hemoglobin-based oxygen carriers are not created equally.
Buehler PW; Alayash AI
Biochim Biophys Acta; 2008 Oct; 1784(10):1378-81. PubMed ID: 18206989
[TBL] [Abstract][Full Text] [Related]
7. Recent and prominent examples of nano- and microarchitectures as hemoglobin-based oxygen carriers.
Jansman MMT; Hosta-Rigau L
Adv Colloid Interface Sci; 2018 Oct; 260():65-84. PubMed ID: 30177214
[TBL] [Abstract][Full Text] [Related]
8. Polymerization of modified diaspirin cross-linked hemoglobin (DCLHb) with 1,6-bismaleimic-hexane.
Qi D; Wang P; Chen C; Guo S; Wang X
Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1069-74. PubMed ID: 26838092
[TBL] [Abstract][Full Text] [Related]
9. [Contributions and prospects of hemoglobin derivatives].
Remy B; Deby-Dupont G; Lamy M
Schweiz Med Wochenschr; 1997 Jun; 127(25):1088-96. PubMed ID: 9312831
[TBL] [Abstract][Full Text] [Related]
10. Processing of ferulic acid modified hemoglobin.
Guo S; Wang P; Chen C; Meng Z; Qi D; Wang X
Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1075-9. PubMed ID: 26838267
[TBL] [Abstract][Full Text] [Related]
11. The proton Bohr factor of native and crosslinker treated hemoglobins--its possible significance for the efficacy of hemoglobin based artificial oxygen carriers.
Barnikol WK
Adv Exp Med Biol; 1994; 361():363-70. PubMed ID: 7597959
[TBL] [Abstract][Full Text] [Related]
12. [Hemoglobin-based oxygen carriers and trials to substitute red blood cells].
Smani Y; Labrude P; Vigneron C; Faivre B
Transfus Clin Biol; 2007 Nov; 14(5):464-73. PubMed ID: 18295525
[TBL] [Abstract][Full Text] [Related]
13. Preparation of unaltered hemoglobin from human placentas for possible use in blood substitutes.
Fasan G; Grandgeorge M; Vigneron C; Dellacherie E
J Biochem Biophys Methods; 1991; 23(1):53-66. PubMed ID: 1918801
[TBL] [Abstract][Full Text] [Related]
14. Subunit-directed click coupling via doubly cross-linked hemoglobin efficiently produces readily purified functional bis-tetrameric oxygen carriers.
Singh S; Dubinsky-Davidchik IS; Yang Y; Kluger R
Org Biomol Chem; 2015 Dec; 13(45):11118-28. PubMed ID: 26400017
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical properties and oxygen affinity of glutaraldehyde polymerized crocodile hemoglobin: the new alternative hemoglobin source for hemoglobin-based oxygen carriers.
Roamcharern N; Payoungkiattikun W; Anwised P; Mahong B; Jangpromma N; Daduang S; Klaynongsruang S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):852-861. PubMed ID: 30873884
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin-based oxygen-carrying solutions: close but still so far.
Levy JH
Anesthesiology; 2000 Mar; 92(3):639-41. PubMed ID: 10719939
[No Abstract] [Full Text] [Related]
17. [Modified hemoglobin solutions as artificial oxygen carriers].
Lenz G; Bissinger U
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():63-7. PubMed ID: 7841783
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of crosslinked and polymerized hemoglobin solutions.
Bakker JC; Berbers GA; Bleeker WK; den Boer PJ; Biessels PT
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):233-41. PubMed ID: 1391437
[TBL] [Abstract][Full Text] [Related]
19. Current status of artificial oxygen carriers.
Spahn DR
Adv Drug Deliv Rev; 2000 Feb; 40(3):143-51. PubMed ID: 10837786
[TBL] [Abstract][Full Text] [Related]
20. Random chemical modification of hemoglobin to identify chloride binding sites in the central dyad axis: their role in control of oxygen affinity.
Manning JM
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(2):199-205. PubMed ID: 8087242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
